The Vietnam animal vaccine market size reached USD 74.48 Million in 2025. Looking forward, the market is expected to reach USD 176.77 Million by 2034, exhibiting a growth rate (CAGR) of 10.08% during 2026-2034. The market is boosted by growing livestock and aquaculture output, rising government attention to preventing disease, and awareness among farmers of the importance of managing animal health. Increasing concern about antibiotic resistance is also promoting preventive healthcare measures in animals, particularly in aquaculture. Local manufacturers are investing in research to develop region-specific vaccines, supported by international collaborations and public health initiatives. These factors collectively contribute to the growth and competitiveness of the Vietnam animal vaccine market share in both domestic and export sectors.
|
Report Attribute
|
Key Statistics
|
|---|---|
|
Base Year
|
2025
|
|
Forecast Years
|
2026-2034
|
|
Historical Years
|
2020-2025
|
| Market Size in 2025 | USD 74.48 Million |
| Market Forecast in 2034 | USD 176.77 Million |
| Market Growth Rate 2026-2034 | 10.08% |
Increasing Government Support and Livestock Disease Control Programs
The market for animal vaccines in Vietnam is expanding rapidly due to the government's growing participation in managing livestock health and disease prevention. In order to combat recurrent outbreaks of illnesses like avian influenza, foot-and-mouth disease, and classical swine fever, the country's agriculture ministry has been working nonstop to implement nationwide immunization programs. In a country where raising livestock is a significant economic activity, these kinds of activities are crucial, particularly for smallholder farmers and rural communities. The government of Vietnam subsidizes or distributes vaccines outright during epidemics to make immunization affordable for farmers. Besides, regional disease monitoring and surveillance systems are being enhanced, particularly at the borders where there is significant movement of livestock. These efforts have fueled demand for advanced as well as traditional animal vaccines. The trend is part of an overall national plan to protect the nation's food supply, minimize economic loss from animal diseases, and enhance the overall productivity and biosecurity of the animal sector.
Increase of Commercial Livestock Production and Export Market Demand
As Vietnam proceeds with its shift away from subsistence agriculture to commercial animal production, demand for animal vaccines is changing very quickly. Large-scale farms, particularly pig and poultry farms, are more and more undertaking systematic vaccination programs to avoid disease outbreaks that would interfere with production and harm export reputation. Vietnam is an important regional exporter of animal products and is subject to strict health and safety standards from international trading partners, and disease control is thus a main priority. Commercial producers need to stay competitive by investing in high-tech veterinary services, such as imported vaccines and biosecurity measures. Foreign-invested farms and joint ventures with foreign agribusiness companies are also changing the pattern of vaccine use by bringing international standards and practices to Vietnam. This change is creating even greater demand for high-quality, multi-valent vaccines and cold-chain logistics solutions. The emphasis on preserving disease-free zones and gaining international health certifications is further propelling modernization and raising the sophistication of vaccine application in Vietnam's animal farming industry.
Expansion of Aquaculture Vaccination and Domestic Innovation
The Vietnam animal vaccine market growth is also being influenced by the country's fast-growing aquaculture industry, led by the Mekong Delta area, which is a world hub for shrimp and fish production. The aquaculture industry used to depend primarily on antibiotics to control disease, but increased pressure on antimicrobial resistance and export bans has driven the industry to adopt preventive approaches, such as vaccines. Vietnamese research institutions and biotech companies are now concentrating on designing aquatic vaccines that meet the country's respective pathogens that are common in their respective localities. Fish and shrimp vaccine innovation, as well as enhanced delivery techniques like immersion and oral vaccines, is gaining strength. Moreover, public-private partnerships are evolving to initiate vaccine research, technology transfer, and capacity building for the aquaculture industry. The necessity to be able to maintain sustainable and disease-resistant production is leading local producers and exporters alike to make vaccination a top-priority long-term health management strategy, and thus, indicating diversification in the animal vaccine industry beyond the conventional livestock.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2026-2034. Our report has categorized the market based on product, animal type, and route of administration.
Product Insights:
The report has provided a detailed breakup and analysis of the market based on the product. This includes attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines.
Animal Type Insights:
A detailed breakup and analysis of the market based on the animal type has also been provided in the report. This includes companion animal (dogs and cats) and livestock animal (cattle, pigs, sheep, and others).
Route of Administration Insights:
The report has provided a detailed breakup and analysis of the market based on the route of administration. This includes subcutaneous, intramuscular, intranasal, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Vietnam, Central Vietnam, and Southern Vietnam.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2025 |
| Historical Period | 2020-2025 |
| Forecast Period | 2026-2034 |
| Units | Million USD |
| Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
| Products Covered | Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, DNA Vaccines |
| Animal Types Covered |
|
| Routes of Administration Covered | Subcutaneous, Intramuscular, Intranasal, Others |
| Regions Covered | Northern Vietnam, Central Vietnam, Southern Vietnam |
| Customization Scope | 10% Free Customization |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: